Xinjingzhiyuan Biotechnology
A company focusing on the development of TCR-T immune cell therapy drugs for solid tumors.
HQ location
China
Website
Launch date
Enterprise value
$110—165m
| Date | Investors | Amount | Round |
|---|---|---|---|
* | CNY200m | Series A | |
| Total Funding | 000k | ||
Related Content
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads